Drug Shortage Report for MYLAN-VERAPAMIL
| Report ID | 162337 |
| Drug Identification Number | 02237922 |
| Brand name | MYLAN-VERAPAMIL |
| Common or Proper name | VERAPAMIL |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
| Strength(s) | 120MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100BT |
| ATC code | C08DA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-06-07 |
| Estimated end date | Unknown |
| Actual end date | 2024-02-14 |
| Shortage status | Resolved |
| Updated date | 2024-02-21 |
| Company comments | Discontinued SKU |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-02-21 | French | Compare |
| v3 | 2024-02-21 | English | Compare |
| v2 | 2022-06-09 | French | Compare |
| v1 | 2022-06-09 | English | Compare |
Showing 1 to 4 of 4